Inflammation Research

, Volume 59, Issue 5, pp 335–338

Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency

  • Annalisa Marcuzzi
  • Giuliana Decorti
  • Alessandra Pontillo
  • Alessandro Ventura
  • Alberto Tommasini
Short Communication



The aim of this study was to evaluate, in a mouse model of mevalonate kinase deficiency (MKD), the possible link between inflammatory symptoms and serum cholesterol levels.

Materials and methods

Balb/c mice were treated with alendronate and bacterial muramyl dipeptide. Body temperature, interleukin-1β (IL-1β) secretion and serum cholesterol levels were measured.


An increased production of the pro-inflammatory cytokine IL-1β (p < 0.05) and a rise in body temperature (p < 0.05) was observed, while, in parallel, serum cholesterol concentration significantly decreased (p < 0.05). These effects were completely reversed when animals were treated with exogenous isoprenoids.


In the mouse model of MKD, the inflammatory response is associated with a reduction in cholesterol levels, and hence this parameter could be used as an indicator of isoprenoid consumption. In addition, plant derived isoprenoids could represent candidate treatments for this disease.


Cholesterol Inflammation Mevalonate kinase deficiency IL-1β Temperature 


  1. 1.
    Fears R. The contribution of the cholesterol biosynthetic pathway to intermediary metabolism and cell function. Biochem J. 1981;199:1–7.PubMedGoogle Scholar
  2. 2.
    Houten SM, Frenkel J, Waterham HR. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci. 2003;60:1118–34.PubMedGoogle Scholar
  3. 3.
    Frenkel J, Rijkers GT, Mandey SH, Buurman SW, Houten SM, Wanders RJ, et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 2002;46:2794–803.CrossRefPubMedGoogle Scholar
  4. 4.
    Houten SM, Wanders RJ, Waterham HR. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta. 2000;1529:19–32.PubMedGoogle Scholar
  5. 5.
    Marcuzzi A, Pontillo A, De Leo L, Tommasini A, Decorti G, Not T, et al. Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res. 2008;64:177–82.CrossRefPubMedGoogle Scholar
  6. 6.
    Newsom DM, Bolgos GL, Colby L, Nemzek JA. Comparison of body surface temperature measurement and conventional methods for measuring temperature in the mouse. Contemp Top Lab Anim Sci. 2004;43:13–8.PubMedGoogle Scholar
  7. 7.
    Mandey SH, Kuijk LM, Frenkel J, Waterham HR. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 2006;54:3690–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Basel AG 2010

Authors and Affiliations

  • Annalisa Marcuzzi
    • 4
  • Giuliana Decorti
    • 2
  • Alessandra Pontillo
    • 3
  • Alessandro Ventura
    • 1
    • 4
  • Alberto Tommasini
    • 1
    • 4
  1. 1.Department of Reproductive and Developmental SciencesUniversity of TriesteTriesteItaly
  2. 2.Department of Life SciencesUniversity of TriesteTriesteItaly
  3. 3.Medical Genetic Service, Institute of Child HealthIRCCS Burlo GarofoloTriesteItaly
  4. 4.Paediatric Division, Institute of Child HealthIRCCS Burlo GarofoloTriesteItaly

Personalised recommendations